Back
Corvus Pharmaceuticals Stock Price Chart
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here
Sell
12
CRVS
Corvus Pharmaceuticals
Last Price:
$5.04
Seasonality Move:
-9.57%
7 Day Trial
ALL ACCESS PASS
$
7
The 7 new tech giants dominating today's markets
Get Your Copy of "These 7 Stocks Will Be Magnificent in 2025" Here.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRVS is experiencing slight selling pressure.
Corvus Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.58 | Sell |
| 20-day SMA: | 7.75 | Sell |
| 50-day SMA: | 8.03 | Sell |
| 200-day SMA: | 4.09 | Buy |
| 8-day EMA: | 6.24 | Sell |
| 20-day EMA: | 7.25 | Sell |
| 50-day EMA: | 7.37 | Sell |
| 200-day EMA: | 4.95 | Buy |
Corvus Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.71 | Sell |
| Relative Strength Index (14 RSI): | 28.05 | Sell |
| Chaikin Money Flow: | -296242 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.66 - 9.1) | Sell |
| Bollinger Bands (100): | (4.21 - 8.29) | Sell |
Corvus Pharmaceuticals Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Corvus Pharmaceuticals Stock
Is Corvus Pharmaceuticals Stock a Buy?
-
Corvus Pharmaceuticals share price is 5.00 while CRVS 8-day simple moving average is 6.58, which is a Sell signal.
-
The stock price of CRVS is 5.00 while Corvus Pharmaceuticals 20-day SMA is 7.75, which makes it a Sell.
-
Corvus Pharmaceuticals 50-day simple moving average is 8.03 while CRVS share price is 5.00, making it a Sell technically.
-
CRVS stock price is 5.00 and Corvus Pharmaceuticals 200-day simple moving average is 4.09, creating a Buy signal.
CRVS Technical Analysis vs Fundamental Analysis
Sell
12
Corvus Pharmaceuticals (CRVS)
is a Sell
Is Corvus Pharmaceuticals a Buy or a Sell?
-
Corvus Pharmaceuticals stock is rated a SellThe current Corvus Pharmaceuticals [CRVS] share price is $5.00. The Score for CRVS is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.
Corvus Pharmaceuticals Stock Info
Market Cap:
321.3M
Price in USD:
5.00
Share Volume:
2.6M
Corvus Pharmaceuticals 52-Week Range
52-Week High:
10.00
52-Week Low:
1.30
Sell
12
Corvus Pharmaceuticals (CRVS)
is a Sell
Corvus Pharmaceuticals Share Price Forecast
-
What is the Corvus Pharmaceuticals stock price today?The Corvus Pharmaceuticals stock price is 5.00 USD today.
-
Will CRVS stock go up or go down?Corvus Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Corvus Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Corvus Pharmaceuticals is overvalued.
Is Corvus Pharmaceuticals Stock a Buy?
-
Corvus Pharmaceuticals share price is 5.00 while CRVS 8-day exponential moving average is 6.24, which is a Sell signal.
-
The stock price of CRVS is 5.00 while Corvus Pharmaceuticals 20-day EMA is 7.25, which makes it a Sell.
-
Corvus Pharmaceuticals 50-day exponential moving average is 7.37 while CRVS share price is 5.00, making it a Sell technically.
-
CRVS stock price is 5.00 and Corvus Pharmaceuticals 200-day simple moving average is 4.95, creating a Buy signal.
Fundamental Analysis of Corvus Pharmaceuticals
Is Corvus Pharmaceuticals a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.38 per share, and an increase next year of $0.46 per share.
Technical Analysis of Corvus Pharmaceuticals
Should I short Corvus Pharmaceuticals stock?
-
CRVS Moving Average Covergence Divergence (MACD) indicator is -0.71, suggesting Corvus Pharmaceuticals is a Sell
-
Corvus Pharmaceuticals Relative Strength Index (RSI) is 28.05, which suggest Corvus Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Corvus Pharmaceuticals is (6.66 - 9.1), which suggest Corvus Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Corvus Pharmaceuticals is (4.21 - 8.29), which suggest Corvus Pharmaceuticals is a Sell
* Corvus Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.